Cargando…

Estimating the In Vivo Killing Efficacy of Cytotoxic T Lymphocytes across Different Peptide-MHC Complex Densities

Cytotoxic T lymphocytes (CTLs) are important agents in the control of intracellular pathogens, which specifically recognize and kill infected cells. Recently developed experimental methods allow the estimation of the CTL's efficacy in detecting and clearing infected host cells. One method, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia, Victor, Richter, Kirsten, Graw, Frederik, Oxenius, Annette, Regoes, Roland R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416789/
https://www.ncbi.nlm.nih.gov/pubmed/25933039
http://dx.doi.org/10.1371/journal.pcbi.1004178
_version_ 1782369279764594688
author Garcia, Victor
Richter, Kirsten
Graw, Frederik
Oxenius, Annette
Regoes, Roland R.
author_facet Garcia, Victor
Richter, Kirsten
Graw, Frederik
Oxenius, Annette
Regoes, Roland R.
author_sort Garcia, Victor
collection PubMed
description Cytotoxic T lymphocytes (CTLs) are important agents in the control of intracellular pathogens, which specifically recognize and kill infected cells. Recently developed experimental methods allow the estimation of the CTL's efficacy in detecting and clearing infected host cells. One method, the in vivo killing assay, utilizes the adoptive transfer of antigen displaying target cells into the bloodstream of mice. Surprisingly, killing efficacies measured by this method are often much higher than estimates obtained by other methods based on, for instance, the dynamics of escape mutations. In this study, we investigated what fraction of this variation can be explained by differences in peptide loads employed in in vivo killing assays. We addressed this question in mice immunized with lymphocytic choriomeningitis virus (LCMV). We conducted in vivo killing assays varying the loads of the immunodominant epitope GP33 on target cells. Using a mathematical model, we determined the efficacy of effector and memory CTL, as well as CTL in chronically infected mice. We found that the killing efficacy is substantially reduced at lower peptide loads. For physiological peptide loads, our analysis predicts more than a factor 10 lower CTL efficacies than at maximum peptide loads. Assuming that the efficacy scales linearly with the frequency of CTL, a clear hierarchy emerges among the groups across all peptide antigen concentrations. The group of mice with chronic LCMV infections shows a consistently higher killing efficacy per CTL than the acutely infected mouse group, which in turn has a consistently larger efficacy than the memory mouse group. We conclude that CTL killing efficacy dependence on surface epitope frequencies can only partially explain the variation in in vivo killing efficacy estimates across experimental methods and viral systems, which vary about four orders of magnitude. In contrast, peptide load differences can explain at most two orders of magnitude.
format Online
Article
Text
id pubmed-4416789
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-44167892015-05-07 Estimating the In Vivo Killing Efficacy of Cytotoxic T Lymphocytes across Different Peptide-MHC Complex Densities Garcia, Victor Richter, Kirsten Graw, Frederik Oxenius, Annette Regoes, Roland R. PLoS Comput Biol Research Article Cytotoxic T lymphocytes (CTLs) are important agents in the control of intracellular pathogens, which specifically recognize and kill infected cells. Recently developed experimental methods allow the estimation of the CTL's efficacy in detecting and clearing infected host cells. One method, the in vivo killing assay, utilizes the adoptive transfer of antigen displaying target cells into the bloodstream of mice. Surprisingly, killing efficacies measured by this method are often much higher than estimates obtained by other methods based on, for instance, the dynamics of escape mutations. In this study, we investigated what fraction of this variation can be explained by differences in peptide loads employed in in vivo killing assays. We addressed this question in mice immunized with lymphocytic choriomeningitis virus (LCMV). We conducted in vivo killing assays varying the loads of the immunodominant epitope GP33 on target cells. Using a mathematical model, we determined the efficacy of effector and memory CTL, as well as CTL in chronically infected mice. We found that the killing efficacy is substantially reduced at lower peptide loads. For physiological peptide loads, our analysis predicts more than a factor 10 lower CTL efficacies than at maximum peptide loads. Assuming that the efficacy scales linearly with the frequency of CTL, a clear hierarchy emerges among the groups across all peptide antigen concentrations. The group of mice with chronic LCMV infections shows a consistently higher killing efficacy per CTL than the acutely infected mouse group, which in turn has a consistently larger efficacy than the memory mouse group. We conclude that CTL killing efficacy dependence on surface epitope frequencies can only partially explain the variation in in vivo killing efficacy estimates across experimental methods and viral systems, which vary about four orders of magnitude. In contrast, peptide load differences can explain at most two orders of magnitude. Public Library of Science 2015-05-01 /pmc/articles/PMC4416789/ /pubmed/25933039 http://dx.doi.org/10.1371/journal.pcbi.1004178 Text en © 2015 Garcia et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Garcia, Victor
Richter, Kirsten
Graw, Frederik
Oxenius, Annette
Regoes, Roland R.
Estimating the In Vivo Killing Efficacy of Cytotoxic T Lymphocytes across Different Peptide-MHC Complex Densities
title Estimating the In Vivo Killing Efficacy of Cytotoxic T Lymphocytes across Different Peptide-MHC Complex Densities
title_full Estimating the In Vivo Killing Efficacy of Cytotoxic T Lymphocytes across Different Peptide-MHC Complex Densities
title_fullStr Estimating the In Vivo Killing Efficacy of Cytotoxic T Lymphocytes across Different Peptide-MHC Complex Densities
title_full_unstemmed Estimating the In Vivo Killing Efficacy of Cytotoxic T Lymphocytes across Different Peptide-MHC Complex Densities
title_short Estimating the In Vivo Killing Efficacy of Cytotoxic T Lymphocytes across Different Peptide-MHC Complex Densities
title_sort estimating the in vivo killing efficacy of cytotoxic t lymphocytes across different peptide-mhc complex densities
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416789/
https://www.ncbi.nlm.nih.gov/pubmed/25933039
http://dx.doi.org/10.1371/journal.pcbi.1004178
work_keys_str_mv AT garciavictor estimatingtheinvivokillingefficacyofcytotoxictlymphocytesacrossdifferentpeptidemhccomplexdensities
AT richterkirsten estimatingtheinvivokillingefficacyofcytotoxictlymphocytesacrossdifferentpeptidemhccomplexdensities
AT grawfrederik estimatingtheinvivokillingefficacyofcytotoxictlymphocytesacrossdifferentpeptidemhccomplexdensities
AT oxeniusannette estimatingtheinvivokillingefficacyofcytotoxictlymphocytesacrossdifferentpeptidemhccomplexdensities
AT regoesrolandr estimatingtheinvivokillingefficacyofcytotoxictlymphocytesacrossdifferentpeptidemhccomplexdensities